Methylphenidate for gait impairment in Parkinson disease: A randomized clinical trial

BACKGROUND: There is a paucity of therapies for gait impairment in Parkinson disease (PD). Open-label studies have suggested improved gait after treatment with methylphenidate (MPD). OBJECTIVE: To evaluate the efficacy of MPD for the treatment of gait impairment in PD. METHODS: Twenty-seven subjects...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Espay, A.J., Dwivedi, A.K., Payne, M., Gaines, L., Vaughan, J.E., Maddux, B.N., Slevin, J.T., Gartner, M., Sahay, A., Revilla, F.J., Duker, A.P., Shukla, R.
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2011
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068005/
https://ncbi.nlm.nih.gov/pubmed/21464430
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182143537
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars